INTRODUCTION: We examined circadian periodicity of atrial tachyarrhythmias (AT/AF) in a large group of patients with implantable devices, which allow continuous collection of the event data over prolonged periods of time. METHODS AND RESULTS: A total of 16,130 AT/AF events were recorded in 236 patients (age: 63 ± 12 years, 27% female, 90% had a history of cardiovascular disease, 33% ischemic, LVEF: 49 ± 18%) over a period of 12 months. To exclude interactions with therapy, the patterns of arrhythmia occurrence were examined for all events and for those episodes that were preceded by at least 1, 6, and 24 hours of sinus rhythm. To prevent biasing toward patients with more frequent episodes, the patterns of AT/AF onset were analyzed both in absolute and patient-normalized (i.e., divided by the total number of events in each patient) units per hour per patient and then summarized for the entire group. In patients with <4 AT/AF events, the onset times were randomly distributed over 24-hour period. However, as the number of AT/AF events increased, a nocturnal pattern of occurrence (determined by the occurrence of a trough around noon) gradually emerged and became highly statistically significant (P < 10(-4) ). The magnitude of nocturnal peak of AT/AF events was well explained by a single-exponential function (R(2) = 0.97, P < 10(-2) ). CONCLUSION: Patients with more frequent atrial tachyarrhythmias are more likely to develop AT/AF at night. Knowledge of patient-specific circadian patterns of arrhythmia occurrence can be useful for personalized management of individuals with significant arrhythmia burden.
INTRODUCTION: We examined circadian periodicity of atrial tachyarrhythmias (AT/AF) in a large group of patients with implantable devices, which allow continuous collection of the event data over prolonged periods of time. METHODS AND RESULTS: A total of 16,130 AT/AF events were recorded in 236 patients (age: 63 ± 12 years, 27% female, 90% had a history of cardiovascular disease, 33% ischemic, LVEF: 49 ± 18%) over a period of 12 months. To exclude interactions with therapy, the patterns of arrhythmia occurrence were examined for all events and for those episodes that were preceded by at least 1, 6, and 24 hours of sinus rhythm. To prevent biasing toward patients with more frequent episodes, the patterns of AT/AF onset were analyzed both in absolute and patient-normalized (i.e., divided by the total number of events in each patient) units per hour per patient and then summarized for the entire group. In patients with <4 AT/AF events, the onset times were randomly distributed over 24-hour period. However, as the number of AT/AF events increased, a nocturnal pattern of occurrence (determined by the occurrence of a trough around noon) gradually emerged and became highly statistically significant (P < 10(-4) ). The magnitude of nocturnal peak of AT/AF events was well explained by a single-exponential function (R(2) = 0.97, P < 10(-2) ). CONCLUSION:Patients with more frequent atrial tachyarrhythmias are more likely to develop AT/AF at night. Knowledge of patient-specific circadian patterns of arrhythmia occurrence can be useful for personalized management of individuals with significant arrhythmia burden.
Authors: S Viskin; M Golovner; N Malov; R Fish; I Alroy; Y Vila; S Laniado; E Kaplinsky; A Roth Journal: Eur Heart J Date: 1999-10 Impact factor: 29.983
Authors: B Braga; D Poyares; F Cintra; C Guilleminault; C Cirenza; S Horbach; D Macedo; R Silva; S Tufik; A A V De Paola Journal: Sleep Med Date: 2008-02-14 Impact factor: 3.492
Authors: V Shusterman; B Aysin; V Gottipaty; R Weiss; S Brode; D Schwartzman; K P Anderson Journal: J Am Coll Cardiol Date: 1998-12 Impact factor: 24.094
Authors: Reena Mehra; Katie L Stone; Paul D Varosy; Andrew R Hoffman; Gregory M Marcus; Terri Blackwell; Osama A Ibrahim; Rawan Salem; Susan Redline Journal: Arch Intern Med Date: 2009-06-22
Authors: Zhen Wang; Srinivas Tapa; Samantha D Francis Stuart; Lianguo Wang; Julie Bossuyt; Brian P Delisle; Crystal M Ripplinger Journal: Circ Arrhythm Electrophysiol Date: 2020-07-24
Authors: Vladimir Shusterman; William C Troy; Medhat Abdelmessih; Stacy Hoffman; Jan Nemec; Patrick J Strollo; Barry London; Rachel Lampert Journal: J Electrocardiol Date: 2015-08-05 Impact factor: 1.438
Authors: Matthias Daniel Zink; Christoph Brüser; Patrick Winnersbach; Andreas Napp; Steffen Leonhardt; Nikolaus Marx; Patrick Schauerte; Karl Mischke Journal: Biomed Res Int Date: 2015-07-01 Impact factor: 3.411
Authors: Andreas Andersen; Jonatan I Bagger; Samuel K Sørensen; Maria P A Baldassarre; Ulrik Pedersen-Bjergaard; Julie L Forman; Gunnar Gislason; Tommi B Lindhardt; Filip K Knop; Tina Vilsbøll Journal: Cardiovasc Diabetol Date: 2021-12-24 Impact factor: 9.951
Authors: Elham Bidar; Stef Zeemering; Martijn Gilbers; Aaron Isaacs; Sander Verheule; Matthias D Zink; Bart Maesen; Sander Bramer; Michal Kawczynski; Isabelle C Van Gelder; Harry J G M Crijns; Jos G Maessen; Ulrich Schotten Journal: Europace Date: 2021-12-07 Impact factor: 5.486